GeroScience

GeroScience (formerly Age; Journal of the American Aging Association) is a scientific journal focused on the biology of aging and on mechanistic studies using clinically relevant models of aging and chronic age-related diseases. The journal also publishes articles on health-related aspects of human aging, including biomarkers of aging, multisystem physiology of aging and pathophysiology of age-related diseases.[1]

GeroScience
DisciplineAging
LanguageEnglish
Edited byZoltan Ungvari, MD, PhD, Veronica Galvan, PhD
Publication details
Former name(s)
Age, Journal of the American Aging Association
History1978–present
Publisher
FrequencyMonthly
7.581 (2021)
Standard abbreviations
ISO 4GeroScience
Indexing
ISSN0161-9152 (print)
1574-4647 (web)
Links

Topics

GeroScience covers topics like chronic low-grade inflammation, cellular senescence, macromolecular damage, oxidative-nitrative stress, maladaptation to cellular and molecular stresses, impaired stem cell function and regeneration, alterations in proteostasis, epigenetic dysregulation, impaired mitochondrial function and cellular metabolism; strategies to improve cardiovascular, neurocognitive, and musculoskeletal health-span; studies using a variety of experimental approaches, including in vivo studies and investigations using isolated tissue preparations and cultured cells; the molecular and cellular mechanisms underlying aging processes; evolutionary biology, biophysics, genetics, genomics, proteomics, molecular biology, cell biology, biochemistry, alternative and complementary medicine (including studies on natural compounds in the context of aging research), gerontology and geriatrics, endocrinology, immunology, physiology, pharmacology, neuroscience, and veterinary sciences (including veterinary pathology). GeroScience also publishes articles in areas of public health and epidemiology relevant for healthy aging. Additionally, GeroScience is a prime outlet for COVID-19 clinical, pathophysiological, immunological and public health-relevant research. GeroScience is currently ranked #4/99 in Geriatrics and Gerontology, #1/86 in Complementary and Alternative Medicine, #5/35 in Biochemistry, Genetics and Molecular Biology/Aging, #1/16 in Veterinary medicine and #21/317 in Cardiology and Cardiovascular Medicine.[2] The 2020 CiteScore value of GeroScience is 9.5 (Elsevier/Scopus). The 2021 Impact Factor of GeroScience is 7.581 (Clarivate Analytics). The current list of open Call-for-Papers (including “Understanding the impact of aging on the susceptibility and response to COVID-19 infection"; “Understanding and overcoming the mechanisms driving age-related sarcopenia“; “Understanding Senescence in Brain Aging and Alzheimer's Disease “ ; “White matter lesions in age-related cognitive decline: etiology, risk factors, prevention and repair“ ; “Brain and Vascular Injury in COVID-19: Implications for Cognitive Dysfunction and the Post-COVID-19 Syndrome”) can be accessed at the journal's website. [3]


Management

It is published by Springer Science+Business Media. The editor-in-Chiefs are Zoltan Ungvari, MD, PhD (from 2020) and Veronica Galvan, PhD (from 2021). Deputy Editor is Holly Brown-Borg, PhD.[4]

References
  1. "American Aging Association". American Aging Association. Retrieved 2018-05-14.
  2. "Scopus - GeroScience data". Retrieved 8 August 2021.
  3. "Call-for-Papers". Retrieved 15 November 2021.
  4. "GeroScience. Details Page: Editorial Board". Springer. Retrieved 14 May 2018.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.